Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$139.01

-8.99 (-6.07%)

20:10
04/20/17
04/20
20:10
04/20/17
20:10

Tesaro CEO responds to Zejula pricing questions, Endpoints News says

Tesaro CEO Lonnie Moulder has responded to questions surrounding the company's pricing of Zejula, saying that "if you read the FDA approved labeling you will see that 69% of patients are down-dosed, which means 31% continue on the 300mg daily starting dose and approximately 70% of the patients will receive either 200mg with a [Wholesale Acquisition Cost] of $9,833 or 100mg with a WAC of $4,917," reports Endpoints News, citing an email from Moulder. According to the report, the CEO added, "The down dosing occurs over the first 1-3 months which is not uncommon for oral anticancer agents as the physician 'dials in' the dose. The median dose and the most common dose were 200mg. Zejula is supplied as a 100mg capsule which means a patient takes either 1 or 2 or 3 capsules once daily based upon what they are prescribed." Reference Link

  • 30

    Jun

TSRO Tesaro
$139.01

-8.99 (-6.07%)

04/20/17
SBSH
04/20/17
NO CHANGE
Target $216
SBSH
Buy
Tesaro price target lowered to $216 from $232 at Citi
Citi analyst Robyn Karnauskas lowered her price target for Tesaro to $216 to reflect the pricing of Zejula. After speaking to management, the analyst expects the net price to be around $9,000, lower than her $10,000 estimate. The price, however, could position the company well for a good launch and future competition, Karnauskas tells investors in a research note. She keeps a Buy rating on Tesaro.
04/20/17
LEER
04/20/17
NO CHANGE
Target $158
LEER
Market Perform
Tesaro price target lowered to $158 from $186 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Tesaro (TSRO) to $158 from $186 on valuation. The analyst notes that the company announced the availability and launch of Zejula as well as pricing of $14,750/month, a 7% premium to Clovis' (CLVS) Rubraca, but he estimates an average pricing of $10,350/month given the frequency of dose reductions. Fernandez reiterates a Market Perform rating on the shares pending the results of TOPACIO and ARIEL3.
04/20/17
RHCO
04/20/17
NO CHANGE
RHCO
Tesaro has no negative read through from AbbVie failure, says SunTrust
SunTrust analyst Peter Lawson says that there is "no impact" on Tesaro's (TSRO) niraparib from the failure of AbbVie's (ABBV) PARP inhibitor, veliparib, in triple negative breast cancer and lung cancer. The analyst believes that niraparib could be more effective than veliparib. Additionally, he notes that during its trial veliparib was used in combination with chemotherapy, while niraparib will be combined with Merck's (MRK) Keytruda for its trial. He thinks that the pairing with Keytruda will result in more effective treatment. The analyst keeps a $235 price target and a Buy rating on Tesaro.
04/20/17
COWN
04/20/17
NO CHANGE
COWN
Tesaro launch of Zejula reduces likelihood of a takeout, says Cowen
Cowen analyst Boris Peaker said Tesaro's launch of Zejula yesterday significantly reduces the likelihood of an "imminent" acquisition. The analyst believes the launch will be a disappointment for some investors that were holding the stock with an expectation for an imminent takeout. As previously discussed, Peaker did not expect a takeout at this stage given potentially significant competitor risk from Clovis's (CLVS) ARIEL3 trial expected to report results this summer. The analyst rates Tesaro a Market Perform with a $145 price target.

TODAY'S FREE FLY STORIES

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:57
09/20/17
09/20
15:57
09/20/17
15:57
Periodicals
Tesla working with AMD on self-driving car AI chip, CNBC says »

Tesla (TSLA) is using AMD…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

NVDA

Nvidia

$187.35

-0.2 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:54
09/20/17
09/20
15:54
09/20/17
15:54
Periodicals
Breaking Periodicals news story on AMD, Tesla »

Tesla working with AMD on…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

15:50
09/20/17
09/20
15:50
09/20/17
15:50
General news
More from Yellen: »

More from Yellen: FOMC…

VIX

Volatility Index S&P 500 Options

15:40
09/20/17
09/20
15:40
09/20/17
15:40
Options
Active trading in VIX calls as players replace expiring positions »

Active trading in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/20/17
09/20
15:35
09/20/17
15:35
General news
Yellen on the FRB »

Yellen on the FRB: she is…

DMPI

DelMar Pharmaceuticals

$1.12

0.0294 (2.70%)

15:33
09/20/17
09/20
15:33
09/20/17
15:33
Syndicate
DelMar Pharmaceuticals announces $10M registered direct offering at-the-market »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$47.94

0.27 (0.57%)

15:30
09/20/17
09/20
15:30
09/20/17
15:30
Options
Far downside put buying in Morgan Stanley »

Far downside put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 22

    Oct

JWN

Nordstrom

$46.13

-0.09 (-0.19%)

15:25
09/20/17
09/20
15:25
09/20/17
15:25
Conference/Events
Nordstrom management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$71.38

-1.1 (-1.52%)

15:25
09/20/17
09/20
15:25
09/20/17
15:25
Options
Bunge call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:25
09/20/17
09/20
15:25
09/20/17
15:25
General news
More from Yellen on inflation »

More from Yellen on…

WFC

Wells Fargo

$53.95

0.591 (1.11%)

15:22
09/20/17
09/20
15:22
09/20/17
15:22
Hot Stocks
Chair Yellen calls Wells Fargo actions 'unacceptable' »

Fed Chair Janet Yellen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 12

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

15:20
09/20/17
09/20
15:20
09/20/17
15:20
General news
The FOMC dot-plot projections »

The FOMC dot-plot…

$NSD

NASDAQ Market Internals

15:17
09/20/17
09/20
15:17
09/20/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

15:16
09/20/17
09/20
15:16
09/20/17
15:16
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

$NYE

NYSE Market Internals

15:16
09/20/17
09/20
15:16
09/20/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$170.00

4.17 (2.51%)

15:14
09/20/17
09/20
15:14
09/20/17
15:14
Conference/Events
Lennox management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

VXX

iPath S&P 500 VIX Short-Term Futures

$41.28

0.37 (0.90%)

15:10
09/20/17
09/20
15:10
09/20/17
15:10
Options
Notable put write in longer-term options on the Short-term VIX ETN »

Notable put write in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:09
09/20/17
09/20
15:09
09/20/17
15:09
General news
Yellen repeats intention to serve out term as chair »

Fed Chair Yellen added…

DLPH

Delphi

$100.88

-0.02 (-0.02%)

, BBRY

BlackBerry

$9.14

-0.12 (-1.30%)

15:05
09/20/17
09/20
15:05
09/20/17
15:05
Hot Stocks
Delphi confirms autonomous driving partnership agreement with BlackBerry »

Delphi Automotive (DLPH)…

DLPH

Delphi

$100.88

-0.02 (-0.02%)

BBRY

BlackBerry

$9.14

-0.12 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UAA

Under Armour

$16.43

-0.38 (-2.26%)

15:00
09/20/17
09/20
15:00
09/20/17
15:00
Options
Under Armour attracts a bullish option play as the slide in shares continues »

Under Armour attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

14:55
09/20/17
09/20
14:55
09/20/17
14:55
General news
Fed Chair Yellen reiterated the FOMC statement »

Fed Chair Yellen…

MLHR

Herman Miller

$34.95

0.1 (0.29%)

14:49
09/20/17
09/20
14:49
09/20/17
14:49
Options
Herman Miller options imply 9.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

SPX

S&P 500

14:47
09/20/17
09/20
14:47
09/20/17
14:47
General news
Yellen says Fed has commitment to raising inflation to 2% »

Federal Reserve Chair…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHD

Church & Dwight

$49.66

-0.91 (-1.80%)

14:47
09/20/17
09/20
14:47
09/20/17
14:47
Syndicate
Breaking Syndicate news story on Church & Dwight »

Church & Dwight files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 07

    Nov

CSBR

Champions Oncology

$3.38

-0.21 (-5.85%)

14:45
09/20/17
09/20
14:45
09/20/17
14:45
Hot Stocks
Champions Oncology receives $2M contract from HHS contract 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.